| Name | 6-(γ,γ-Dimethylallylamino)purine |
| Description | 6-(γ,γ-Dimethylallylamino)purine (Triacanthine), which is a plant growth substance, shows hypertensive and antitumor activity, also cardiotonic, antispasmodic and a respiratory analeptic. |
| In vitro | 6-(γ,γ-Dimethylallylamino)purinee significantly inhibited EJ cell proliferation (IC50 600μM). Flow cytometry analysis revealed that cells were arrested in the G1 phase, and apoptotic cells accumulated in the sub-G1 phase in a dose-dependent manner. 6-(γ,γ-Dimethylallylamino)purinee inhibited the G1-S transition by deterring complex formation between cyclin-dependent kinases and cyclins, thereby up-regulating cell cycle inhibitors p21WAF1 and p27KIP1. |
| In vivo | In an in vivo study, 6-(γ,γ-Dimethylallylamino)purinee significantly limited growth of xenografted tumors. Interestingly, while cisplatin resulted in significant weight loss after a 5-mg/kg dose, 6-(γ,γ-Dimethylallylamino)purinee did not cause weight loss, behavioral abnormalities, altered biochemical parameters, or tissue staining. A single oral dose acute-toxicity test (6-(γ,γ-Dimethylallylamino)purinee 2,000mg/kg) produced no adverse cytotoxic effects via blood biochemical tests and tissue-organ staining. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 2.03 mg/mL (10 mM), Sonication is recommended.
|
| Keywords | 6-(r,r-Dimethylallylamino)purine | 6-(γ,γ-Dimethylallylamino)purine | 6(γ,γDimethylallylamino)purine | inhibit | 6 (γ,γ Dimethylallylamino)purine | Inhibitor | 6-(gamma,gamma-Dimethylallylamino)purine |
| Related Compound Libraries | Anti-Tumor Natural Product Library | Pesticide Compound Library | Bioactive Compound Library | Traditional Chinese Medicine Monomer Library | Selected Plant-Sourced Compound Library | Natural Product Library | Tobacco Monomer Library | Natural Product Library for HTS | Bioactive Compounds Library Max | Anti-Cancer Active Compound Library |
United States
